Revision of Deep Brain Stimulator in Patients With Parkinson's Disease
Recruiting · NCT07176494 · Interventional (participants receive a specific treatment) · Lead sponsor: Ankara Etlik City Hospital
View the official record on ClinicalTrials.gov →Interventions studied
What this trial is about
Parkinson's disease is a chronic and progressive neurodegenerative disease that affects the central nervous system, particularly impairing movement control. It is associated with the loss of dopamine-producing cells in the brain and typically occurs in middle age and beyond. Deep brain stimulation (DBS) is considered when symptoms of Parkinson's disease, such as tremors, slowed movements, and muscle rigidity, are not adequately controlled with medications. Selected patients with severe symptoms that do not respond to medical treatment are generally considered for this treatment. Battery revision surgeries can be performed under general anesthesia or regional anesthesia. Patients undergoing general anesthesia should be cautious about the potential complications of general anesthesia, while those undergoing regional anesthesia should be cautious about the local anesthetic systemic toxicity. Because each method has its own advantages, the choice of anesthesia may vary. This study aimed to compare postoperative analgesic efficacy and patient satisfaction in patients who underwent surgery under general anesthesia or sedation-assisted battery replacement under regional anesthesia. Both anesthesia methods are routinely used in Parkinson's disease patients undergoing battery replacement.
Who can take part
Inclusion criteria
- Those aged 40-85
- Those with an ASA score of I-II-III
- Those with a body mass index (BMI) between 18-30
Exclusion criteria
- Those under 40 and over 85
- Those with an ASA score of IV or higher
- Those with a BMI of under 18 and over 30
Where it is running
1 location listed.
- Ankara Etlik City Hospital - Ankara, Yenimahalle\Ankara, Turkey (Türkiye)